TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34521593

Group type: EXPERIMENTAL
Intervention: 1,25-hydroxyvitamin D3 plus amoxicillin, clarithromycin, and esomeprazole for 2 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard clarithromycin-based triple therapy (amoxicillin, clarithromycin, and esomeprazole for 2 weeks)
Number of subjects: 150
Study: 35737833

Group type: EXPERIMENTAL
Intervention: Transfluthrin-based spatial repellent
Number of subjects: 16783
Study: 32200819

Group type: EXPERIMENTAL
Intervention: Treatment group 1
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Treatment group 2
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Treatment group 3
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Baseline visual acuity
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 438
Study: 36178909

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 90
Study: 35129534

Group type: EXPERIMENTAL
Intervention: 4-day antibiotic duration (experimental arm of STOP-IT RCT)
Number of subjects: 4384

Group type: COMPARATOR
Intervention: Standard antibiotic duration (control group)
Number of subjects: 4384
Study: 32366554

Group type: EXPERIMENTAL
Intervention: Local network feature model
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Global network feature model
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined model of local and global features
Number of subjects: 40
Study: 33369038

Group type: EXPERIMENTAL
Intervention: FAMily‐Oriented Support (FAMOS) intervention, cognitive-behavioural manualised home intervention for 6 months
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: FAMily‐Oriented Support (FAMOS) intervention
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual psychosocial care (Control)
Number of subjects: 109
Study: 33225918

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) treatment
Number of subjects: 5679
Study: 36163806

Group type: EXPERIMENTAL
Intervention: Ivosidenib (IVO) 500 mg once daily plus Azacitidine (AZA) 75 mg/m2 for 7 days in 28-day cycles
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo (PBO) plus Azacitidine (AZA) 75 mg/m2 for 7 days in 28-day cycles
Number of subjects: 146
Study: 34628889

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (800-1,200 IU/day)
Number of subjects: 184

Group type: COMPARATOR
Intervention: ATD (methimazole, 15-30 mg/day)
Number of subjects: 184
Study: 36055467

Group type: EXPERIMENTAL
Intervention: H‐1337 Ophthalmic Solution 0.06%
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: H‐1337 Ophthalmic Solution 0.20%
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: H‐1337 Ophthalmic Solution 0.60%
Number of subjects: 87

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: H‐1337 (all doses combined)
Number of subjects: 87
Study: 33773189

Group type: EXPERIMENTAL
Intervention: Carvacrol (1.2 mg/kg/day, n = 17)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (n = 16)
Number of subjects: 33
Study: 34505292

Group type: EXPERIMENTAL
Intervention: 3-month psychological intervention in addition to standard physiological treatment
Number of subjects: 143

Group type: COMPARATOR
Intervention: Standard physiological treatment
Number of subjects: 143
Study: 33941155

Group type: EXPERIMENTAL
Intervention: MoM LDH THA
Number of subjects: 48

Group type: COMPARATOR
Intervention: HR
Number of subjects: 48
Study: 35861850

Group type: EXPERIMENTAL
Intervention: Chinese heart‐healthy diet
Number of subjects: 265

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 265
Study: 34543244

Group type: EXPERIMENTAL
Intervention: Half-dose photodynamic therapy (PDT)
Number of subjects: 146

Group type: COMPARATOR
Intervention: High-density subthreshold micropulse laser
Number of subjects: 146
Study: 35543079

Group type: EXPERIMENTAL
Intervention: Curettage
Number of subjects: 97

Group type: COMPARATOR
Intervention: Cryosurgery
Number of subjects: 97
Study: 34822339

Group type: EXPERIMENTAL
Intervention: Rational messages
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Emotional messages
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Simple messages
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: All participants (overall effect)
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Emotional messages (overall effect)
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Complex messages (overall effect)
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: Loss-framed messages (overall effect)
Number of subjects: 636
Study: 35552364

Group type: EXPERIMENTAL
Intervention: Etirinotecan pegol, 145 mg/m2, every 21 days
Number of subjects: 178

Group type: COMPARATOR
Intervention: Chemotherapy (eribulin, ixabepilone, vinorelbine, gemcitabine, paclitaxel, docetaxel, or nab-paclitaxel)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Etirinotecan pegol
Number of subjects: 178

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 178
Study: 33583203

Group type: EXPERIMENTAL
Intervention: Personalized virtual reality
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-personalized virtual reality
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 26
Study: 32707097

Group type: EXPERIMENTAL
Intervention: Enhanced workspace configuration (ergonomically optimized)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Current workspace configuration (not ergonomically optimized)
Number of subjects: 14
Study: 34009326

Group type: EXPERIMENTAL
Intervention: Alivecor® KardiaMobile ECG monitor usage
Number of subjects: 105
Study: 35164488

Group type: EXPERIMENTAL
Intervention: U‐P‐needle group (ultrasound probe perpendicular to the needle)
Number of subjects: 59

Group type: COMPARATOR
Intervention: U‐P‐artery group (ultrasound probe perpendicular to the artery)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: U‐P‐needle group
Number of subjects: 59

Group type: COMPARATOR
Intervention: U‐P‐artery group
Number of subjects: 59
Study: 32318871

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus docetaxel
Number of subjects: 1253

Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 1253
Study: 32087337

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2400 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35418247

Group type: EXPERIMENTAL
Intervention: Values-affirmation intervention on medication adherence
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Financial-resource strain
Number of subjects: 825

Group type: EXPERIMENTAL
Intervention: Being uninsured
Number of subjects: 825
Study: 33554750

Group type: EXPERIMENTAL
Intervention: Planning + education intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Education-only condition
Number of subjects: 102
Study: 33433171

Group type: EXPERIMENTAL
Intervention: ART (Antiretroviral Therapy)
Number of subjects: 3777

Group type: COMPARATOR
Intervention: No ART
Number of subjects: 3777
Study: 32963511

Group type: EXPERIMENTAL
Intervention: Supervised machine learning methods (linear classifiers and probabilistic classifiers)
Number of subjects: 30000
Study: 33335847

Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention (IBI) with only automated support by the system
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention (IBI) with minimal human support
Number of subjects: 153

Group type: COMPARATOR
Intervention: Waiting list group
Number of subjects: 153
Study: 33176757

Group type: EXPERIMENTAL
Intervention: Hyperthermic baths (HTB) twice weekly for 8 weeks (n = 22)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Physical exercise program (PEP) of moderate intensity twice weekly for 8 weeks (n = 23)
Number of subjects: 45
Study: 35237338

Group type: EXPERIMENTAL
Intervention: Needle-warming moxibustion combined with hyperbaric oxygen therapy (NWM + HBOT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Needle-warming moxibustion (NWM)
Number of subjects: 100
Study: 32335122

Group type: EXPERIMENTAL
Intervention: GRASP MRI with temporal resolution of 4.1 s
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GRASP MRI with semiquantitative analysis of time intensity curves
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GRASP MRI in presumed paragangliomas and schwannomas
Number of subjects: 6
Study: 35863947

Group type: EXPERIMENTAL
Intervention: 4 mL bolus every 45 min
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 6 mL bolus every 45 min
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: 8 mL bolus every 45 min
Number of subjects: 210
Study: 34687398

Group type: EXPERIMENTAL
Intervention: Avelumab + utomilumab + rituximab (arm A)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Avelumab + utomilumab + azacitidine (arm B)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Avelumab + bendamustine + rituximab (arm C)
Number of subjects: 29
Study: 35262373

Group type: EXPERIMENTAL
Intervention: Mixed Reality (MR) technology
Number of subjects: 92
Study: 34238445

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg plus Ezetimibe 10 mg (ATO10/EZE10)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg alone (ATO40)
Number of subjects: 41
Study: 35576957

Group type: EXPERIMENTAL
Intervention: tiragolumab plus atezolizumab
Number of subjects: 275

Group type: COMPARATOR
Intervention: placebo plus atezolizumab
Number of subjects: 275
Study: 34698750

Group type: EXPERIMENTAL
Intervention: 100% Concord grape juice (CGJ) consumed with a meal
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Polyphenol-free grape flavored drink with customary flavor essence (LP) consumed with a meal
Number of subjects: 34

Group type: COMPARATOR
Intervention: Polyphenol-free grape flavored drink with reduced flavor essence (LPF) consumed with a meal
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: 100% Concord grape juice (CGJ) consumed alone
Number of subjects: 34

Group type: COMPARATOR
Intervention: Polyphenol-free grape flavored drink without CG phenolics and reduced flavor essence (LPF) consumed alone
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cognitive outcomes (assessed hourly through visual analog scales)
Number of subjects: 34
Study: 32483186

Group type: EXPERIMENTAL
Intervention: Community pharmacy-based intervention for IAR
Number of subjects: 125

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 125
Study: 37257948

Group type: EXPERIMENTAL
Intervention: High-intensity care with rapid uptitration of oral medications for heart failure
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1078
Study: 32852632

Group type: EXPERIMENTAL
Intervention: Daratumumab subcutaneous (DARA SC)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Daratumumab intravenous (DARA IV)
Number of subjects: 522
Study: 34242085

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging-guided focused ultrasound surgery (MRgFUS)
Number of subjects: 37

Group type: COMPARATOR
Intervention: UAE
Number of subjects: 37

Group type: COMPARATOR
Intervention: MRgFUS
Number of subjects: 37
Study: 33083852

Group type: EXPERIMENTAL
Intervention: Probiotic lozenges (Lactobacillus brevis CD2)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 32159243

Group type: EXPERIMENTAL
Intervention: Peer mentorship
Number of subjects: 60

Group type: COMPARATOR
Intervention: Social support mentorship
Number of subjects: 60
Study: 35809628

Group type: EXPERIMENTAL
Intervention: iCare PRO tonometer
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: iCare IC200 tonometer
Number of subjects: 101

Group type: COMPARATOR
Intervention: Goldmann applanation tonometer (GAT)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Visual analog scale for comfort
Number of subjects: 101
Study: 33514427

Group type: EXPERIMENTAL
Intervention: High dose umbilical cord MSCs (200 × 10^6 cells, 3 infusions every other day for a total of 600 × 10^6 cells)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High dose placental MSCs (200 × 10^6 cells, 3 infusions every other day for a total of 600 × 10^6 cells)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: High dose MSCs (both UC-MSCs and PL-MSCs)
Number of subjects: 11
Study: 34196886

Group type: EXPERIMENTAL
Intervention: Tobacco heating product (THP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (abstaining from cigarette smoking)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuing smokers (cigarette smoking)
Number of subjects: 0
Study: 35054083

Group type: EXPERIMENTAL
Intervention: Early warning system (EWS) and hemodynamic algorithm
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study: 35020488

Group type: EXPERIMENTAL
Intervention: Closed-loop control (Tandem Control-IQ)
Number of subjects: 112
Study: 33507929

Group type: EXPERIMENTAL
Intervention: 0.5 ml/kg buccal 40% dextrose gel
Number of subjects: 2149

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 2149
Study: 32805715

Group type: EXPERIMENTAL
Intervention: Minds in Motion (MiM) The Maze
Number of subjects: 48

Group type: COMPARATOR
Intervention: Yoga
Number of subjects: 48
Study: 34018341

Group type: EXPERIMENTAL
Intervention: n-HAP
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: NSF
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (placebo gel)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: CPP-ACP
Number of subjects: 64
Study: 36231933

Group type: EXPERIMENTAL
Intervention: Ischemic intra-conditioning at 60% arterial occlusion pressure
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ischemic intra-conditioning at 80% arterial occlusion pressure
Number of subjects: 34

Group type: COMPARATOR
Intervention: Without ischemic intra-conditioning
Number of subjects: 34
Study: 34485529

Group type: EXPERIMENTAL
Intervention: TENS+taping
Number of subjects: 46

Group type: COMPARATOR
Intervention: TENS
Number of subjects: 46
Study: 35954979

Group type: EXPERIMENTAL
Intervention: Exercise toolkit intervention (stick, theraband, sandbag, small ball) led by a physical therapist, 90 min per session, twice weekly for 3 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual CCS activity program
Number of subjects: 90
Study: 34803399

Group type: EXPERIMENTAL
Intervention: Transversus thoracic muscle plane block (TTPB) with general anesthesia (GA) and 15 mL of 0.25% bupivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transversus thoracic muscle plane block (TTPB) with GA and 15 mL of 0.25% bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia (GA) with saline injection
Number of subjects: 60
Study: 36055039

Group type: EXPERIMENTAL
Intervention: Machine learning model based on diffusion-weighted imaging (DWI) radiomics features
Number of subjects: 260
Study: 33039316

Group type: EXPERIMENTAL
Intervention: Educational pamphlet
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 137
Study: 32740972

Group type: EXPERIMENTAL
Intervention: Dexamethasone 6 mg once per day for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 32444221

Group type: EXPERIMENTAL
Intervention: Strength intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 35323067

Group type: EXPERIMENTAL
Intervention: Intact RC/SC
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both structures sectioned
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: RC sectioned first
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SC sectioned first
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: RC repair
Number of subjects: 12
Study: 35010916

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg twice daily)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 33405284

Group type: EXPERIMENTAL
Intervention: Routine-based cue planning
Number of subjects: 192

Group type: COMPARATOR
Intervention: Time-based cue planning
Number of subjects: 192
Study: 32980829

Group type: COMPARATOR
Intervention: Chlorhexidine (0.2%)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Chitosan (0.5%)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Chlorhexidine - Chitosan combination
Number of subjects: 3
Study: 36355920

Group type: EXPERIMENTAL
Intervention: Smartphone-based CBT-I app
Number of subjects: 175

Group type: COMPARATOR
Intervention: Sham app
Number of subjects: 175
Study: 33914140

Group type: EXPERIMENTAL
Intervention: Daytime sleepiness
Number of subjects: 20806
Study: 33287874

Group type: EXPERIMENTAL
Intervention: Visual EEG features
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Visual EEG features + clinical features
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Visual EEG features for HIE patients
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Visual EEG features for TBI patients
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Visual EEG features for metabolic, inflammatory or infectious causes
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Visual EEG features for stroke patients
Number of subjects: 364
Study: 33440437

Group type: EXPERIMENTAL
Intervention: EUS-guided intratumoral radioactive phosphorus-32 (32P) implantation followed by six chemotherapy cycles
Number of subjects: 12
Study: 33058473

Group type: EXPERIMENTAL
Intervention: OL‐HDF
Number of subjects: 97
Study: 33386633

Group type: EXPERIMENTAL
Intervention: Participation-focused leisure-time physical activity intervention
Number of subjects: 33
Study: 32732620

Group type: EXPERIMENTAL
Intervention: Auricular neurostimulation
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sham control (placebo)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: High vagal efficiency treatment group
Number of subjects: 92
Study: 35699170

Group type: EXPERIMENTAL
Intervention: Low-dose rivaroxaban
Number of subjects: 6564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6564

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 6564
Study: 32536547

Group type: EXPERIMENTAL
Intervention: RTS,S/AS02 malaria vaccine
Number of subjects: 0
Study: 36100927

Group type: EXPERIMENTAL
Intervention: HBOT (Hyperbaric Oxygen Treatment)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard trauma care
Number of subjects: 120
Study: 32564365

Group type: EXPERIMENTAL
Intervention: Lidocaine (bolus of 1.5 mg.kg−1, continuous infusion of 2 mg.kg−1.h−1 until end of surgery, then 1 mg.kg−1.h−1 for 1 hour in recovery)
Number of subjects: 176

Group type: COMPARATOR
Intervention: 0.9% saline (identical volumes and rates)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion
Number of subjects: 176
Study: 32772366

Group type: EXPERIMENTAL
Intervention: Minimally invasive left pancreatectomy (MIS LP)
Number of subjects: 1610

Group type: EXPERIMENTAL
Intervention: Robotic left pancreatectomy
Number of subjects: 1610
Study: 34060209

Group type: EXPERIMENTAL
Intervention: Oral semaglutide (initial 3 mg dose)
Number of subjects: 782
Study: 32940243

Group type: EXPERIMENTAL
Intervention: Gain-framed public health message promoting the benefits of screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment attributes (effectiveness and out-of-pocket cost)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monetary incentive for screening
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correcting misconceptions about screen-detected cancer prognosis or providing greater financial protection
Number of subjects: 0
Study: 34153592

Group type: EXPERIMENTAL
Intervention: Percutaneous patent foramen ovale closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 0
Study: 32544350

Group type: COMPARATOR
Intervention: Cytokines (IL-6, IL-8, IL-10) levels in patients with benign and malignant neoplasia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokines (IL-6, IL-8, IL-10) levels in ovarian cancer patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment (post-surgery)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cut-off values for IL-6, IL-8, and IL-10
Number of subjects: 0
Study: 34534404

Group type: EXPERIMENTAL
Intervention: Induction of labour at 41 weeks of gestation
Number of subjects: 1373

Group type: COMPARATOR
Intervention: Expectant management until 42 weeks of gestation
Number of subjects: 1373
Study: 33187116

Group type: EXPERIMENTAL
Intervention: Cognitive–behavioral conference call intervention (CBCC)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Behavioral-activation conference call intervention (BACC)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Usual care control group (CG)
Number of subjects: 219
Study: 35793732

Group type: EXPERIMENTAL
Intervention: Phone-only visits
Number of subjects: 200

Group type: COMPARATOR
Intervention: Video visits
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 200
Study: 34593022

Group type: EXPERIMENTAL
Intervention: Contralateral exploration during unilateral hernia repair
Number of subjects: 378

Group type: COMPARATOR
Intervention: No contralateral exploration during unilateral hernia repair
Number of subjects: 378
Study: 32428620

Group type: EXPERIMENTAL
Intervention: simplified LBBaP (s‐LBBaP)
Number of subjects: 51

Group type: COMPARATOR
Intervention: conventional LBBaP (c‐LBBaP)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: s‐LBBaP
Number of subjects: 51
Study: 35150301

Group type: EXPERIMENTAL
Intervention: Speed of Processing Training (SOPT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo Control
Number of subjects: 84
Study: 34082905

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft (CABG)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Life expectancy
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Quality of life (QOL) status
Number of subjects: 575
Study: 32378922

Group type: EXPERIMENTAL
Intervention: 4-week mindfulness-based training (MBT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: 4-week adaptive cognitive training (aCT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 61
Study: 34753425

Group type: EXPERIMENTAL
Intervention: TMQLB with 0.4 ml/kg 0.5% ropivacaine
Number of subjects: 72

Group type: COMPARATOR
Intervention: 0.9% saline as placebo
Number of subjects: 72
Study: 32335605

Group type: EXPERIMENTAL
Intervention: Medical Abortion
Number of subjects: 160

Group type: COMPARATOR
Intervention: Manual Vacuum Aspiration
Number of subjects: 160